相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice
M. Buysschaert et al.
DIABETES & METABOLISM (2010)
Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study
Stephen Jones et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargine
Rosalind Fabunmi et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
STATEMENT BY AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CONSENSUS PANEL ON TYPE 2 DIABETES MELLITUS: AN ALGORITHM FOR GLYCEMIC CONTROL
Helena W. Rodbard et al.
ENDOCRINE PRACTICE (2009)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
David C. Klonoff et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK
A. Rubino et al.
DIABETIC MEDICINE (2007)
Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: A multinational, randomized, open-label, two-period, crossover noninferiority trial
Anthony H. Barnett et al.
CLINICAL THERAPEUTICS (2007)
Rinnonabant as an adjunct therapy in overweight/obese patients with type 2 diabetes: reply
Lars Ryden et al.
EUROPEAN HEART JOURNAL (2007)
Delay of insulin addition to oral combination therapy despite inadequate glycemic control
Gregory A. Nichols et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2007)
A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study
M. A. Nauck et al.
DIABETOLOGIA (2007)
Statistical and regulatory issues with the application of propensity score analysis to nonrandomized medical device clinical studies
Lilly Q. Yue
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2007)
Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes - A randomized trial
RJ Heine et al.
ANNALS OF INTERNAL MEDICINE (2005)
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea
DM Kendall et al.
DIABETES CARE (2005)
The burden of treatment failure in type 2 diabetes
JB Brown et al.
DIABETES CARE (2004)
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
JB Buse et al.
DIABETES CARE (2004)
Observational research methods. Research design II: cohort, cross sectional, and case-control studies
CJ Mann
EMERGENCY MEDICINE JOURNAL (2003)
Adaptation of the Diabetes Health Profile (DHP-1) for use with patients with Type 2 diabetes mellitus:: psychometric evaluation and cross-cultural comparison
KA Meadows et al.
DIABETIC MEDICINE (2000)
分享论文
